A study in Japan found that antifibrotic treatment rates for patients with idiopathic pulmonary fibrosis (IPF) varied by ...

is driving the idiopathic pulmonary fibrosis treatment market. New York, USA, Nov. 20, 2024 (GLOBE NEWSWIRE) -- market Overview: Polaris Market Research's latest analysis reveals that the market ...

Dr Tim Oldham unpacks what IPF is, who it impacts, and what the company is doing in the fight against it with AD-214.

Since her IPF diagnosis in 2016, columnist Charlene Marshall has learned to manage her emotions — expect when a loved one gets the same news.

New York, USA, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Market Overview: Polaris Market Research's latest analysis reveals that the market for idiopathic pulmonary fibrosis treatment is on a growth ...

The trial outcomes for ENV-101 demonstrated statistically significant improvements in lung function and lung capacity.

The ILD Summit is accredited by the American Association of Continuing Medical Education (ACCME) and the British Academy of ...

( MENAFN - Mid-East Info) Interstitial Lung disease Summit 2024 brings together more than 140 healthcare professionals from ...

The increase in the global burden of interstitial lung disease (ILD) and pulmonary sarcoidosis had the greatest impact on ...

Type 1 invariant (iNKT) cells play a critical role in propagating the injury, inflammatory response, and fibrosis observed in inflammatory and fibrotic indications. GRI Bio’s lead program, GRI-0621, ...